Fytexia is a emerging leader in the development of innovative, ready-to-use solutions dedicated to the dietary nutrition industry and validated by extensive third-party scientific research and testing.

Fytexia has developed a unique offering around a range of 5 proprietary ingredients with demonstrable efficacy supported by clinical studies which have subsequently been published as peer-reviewed articles in well-cited scientific journals.

Founded in 2003 and headquartered near Béziers (France), the Company opened a subsidiary in the US in 2013 to meet the strong demand in the American market. An office has also been established in Malaysia, to service the rapidly growing Asian market.

www.fytexia.com

INVESTMENT DATE 
2016

SECTOR
Consumer Health

TRANSACTION TYPE 
Buy-Out

GROWTH THEME 
Development of the product portfolio

LOCATION
France